Darshan Doshi on Results of iMODERN and ILIAS ANOCA Studies Presented at TCT 2025
Darshan Doshi, Chief Medical Officer for Image-Guided Therapy Devices at Philips, shared on LinkedIn:
”Proud to share that today at TCT 2025, Philips has announced the 3-year results from the iMODERN trial, the largest global study to date using Class IA-recommended iFR in heart attack patients with multi-vessel disease.
This late-breaking data confirms that treating additional blocked arteries during the initial procedure is just as safe as waiting for a follow-up, giving clinicians more flexibility to personalize care and potentially reduce additional hospital visits.
These results directly address a longstanding question in interventional cardiology and reinforce the evidence base for physiology-guided treatment strategies.
In addition, new results from the ILIAS ANOCA study, also presented at TCT, highlight the sustained benefits of physiology-guided assessment and tailored medical therapy for patients with angina but no obstructive coronary arteries.
Together, these studies underscore the value of integrating advanced physiology solutions in decision-making across the spectrum of cardiovascular care.
Congratulations to the iMODERN and ILIAS ANOCA teams, and sincere thanks to the investigators and patients who made this research possible.
Read more in the press release.”
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 13:53Steven Lubega: Why Are Healthy Newborns Born Poorly Equipped To Stop Bleeding?
-
Aug 11, 2026, 13:47Why Stroke Risk Changes During Pregnancy – International Journal of Stroke
-
Aug 11, 2026, 13:43Moyahabo Julius Rampya: Shaping the Future of Stroke Care in Africa
-
Aug 11, 2026, 13:34Brett Hoover: Plaque Burden May Be Key to Predicting MACE Risk
-
Aug 11, 2026, 11:47Rucha Patil: Strengthening Evidence-Based Haemophilia Care Across India
-
Aug 11, 2026, 11:38Maria Hadjidemetriou: The Patient Perspective in Thalassemia Care
-
Aug 11, 2026, 11:04Wolfgang Miesbach: The Critical Need for Tailored Dosing in VWD
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC